Company profile
Veraxa Biotech AG - Post de-SPAC
NASDAQ:VRXABiotechnology: Pharmaceutical Preparations
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.